← Leaderboards
Joseph P Steiner
Biomedisyn Corporation
$2,955,508
Attributed
$2,955,508
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $850.1K · FY2010–15$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,955,508 · 3
By mechanism
P30$2,349,993 · 1
R01$354,352 · 1
R41$251,163 · 1
Top collaborators
No co-investigators on record.
Most similar at Biomedisyn Corporation
Same institution · by research overlap
- Christopher G. Conrad$246,905
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsOxidative StressBrainNeurocognitiveAids/Hiv ProblemHighly Active Antiretroviral TherapyDrug KineticsPre-ClinicalTherapeutic AgentsIn VitroIn VivoResearch PersonnelNational Institute Of Mental Health (U.S.)NeurobiologyMedicalGlobal HealthHippocampus (Brain)Novel StrategiesInstructionCombinatorialAmericasInflammationIn Vitro ModelBiopharmaceutics
Grant awards (8)
Therapeutic Core$446,817
P30 · FY2015 · MH · contact PI
Therapeutic Core$450,396
P30 · FY2014 · MH · contact PI
Therapeutic Core$471,276
P30 · FY2013 · MH · contact PI
Therapeutic Core$467,739
P30 · FY2012 · MH · contact PI
Therapeutic Core$17,988
P30 · FY2012 · MH · contact PI
Therapeutic Core$495,777
P30 · FY2011 · MH · contact PI
SSRI-neuroprotection for HIV/drug abuse$354,352
R01 · FY2011 · DA · contact PI
Neuroprotective and Antiviral Effects of BMD-101 and BMD-104 in HIV Infection$251,163
R41 · FY2010 · MH · contact PI